Use of Dashanga Guggulu and Kansa Haritaki Avaleha in Hypothyroidism along with obesity

Efficacy of Dashanga Guggulu and Kansa Haritaki Avaleha as add on in the management of Hypothyroidism associated with obesity A Standard Controlled Single Blind Clinical Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/04/041577

Enrollment

Registered

2022-04-01

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E038- Other specified hypothyroidism

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: i. Patients having clinical features of Hypothyroidism and S.TSH level above >4.25mIU/mL and having BMI=25kg/m2 ii. Age 18-60 years of either sex iii. Patient willing to give their consent to participate in the study.

Exclusion criteria

Exclusion criteria: i. Patients suffering from Secondary Hypothyroidism, Hashimoto thyroiditis ii. Chronicity of hypothyroidism more than 10 year iii. Pregnancy, lactating mothers iv. Patients having associated diseases like ischemic heart diseases, uncontrolled hypertension(160/100 mm of Hg), uncontrolled diabetes(RBS >200mg/dl), myocardial infarction, cerebrovascular events, cardiac arrhythmias, malignancy and suffering from psychosis v. Patients age below 18 years and above 60 years of either sex.

Design outcomes

Primary

Measure	Time frame
Reduction in Serum.TSH levelTimepoint: On 0 day and after 6 weeks	—

Secondary

Measure	Time frame
i. Improvement in signs & symptom of hypothyroidism ii. Reduction in weight iii. To improve the quality of life iv. Status of Agni Timepoint: On 0 day and after 6 weeks	—

Countries

India

Contacts

Public ContactDr Mandip Goyal

I.T.R.A . Jamnagar

director@itra.edu.in9427776660

Outcome results